SUMMARY Immunisation with heterologous type II collagen (CII) induces arthritis in mice of the DBA/1 strain, which is genetically susceptible to this disease. To develop an experimental model of autoimmunity more adequate for the study of human rheumatoid arthritis (RA), DBA/1 mice were injected with 100 ,tg of native CII that had been purified from mouse xiphoid cartilage. About six weeks later the animals developed a chronic progressive polyarthritis involving the four paws but mainly confined to interphalangeal and metatarsophalangeal joints. The evolution of the disease fluctuated between remissions and exacerbations. The initial lesions assessed by clinical observations were more severe when the disease occurred early than in the case of late onset. Interestingly, the incidence of arthritis was clearly preponderant in males, and, moreover, the few female mice which developed arthritis had mild disease states with lower arthritic scores than the males. Varying levels of autoantibodies against mouse CII were found in the sera of immunised animals, regardless of the development of arthritis. These data indicate that the injection of homologous CII into mice caused a polyarthritis that is clinically closer to the human RA than the disease induced with heterologous CII and therefore will represent a useful tool for the study of the self-perpetuating mechanisms that characterise RA.
Rheumatoid arthritis (RA) is characterised by a chronic proliferative synovitis of diarthrodial joints that eventually leads to articular cartilage and bone erosion. The precise nature of the immune reactions that take place in the synovial tissue in RA is poorly understood. It has been postulated that the massive infiltrates of helper T cells in close contact with HLR-DR+ synovial stellate cells are mutually stimulatory, supporting the existence of a local selfperpetuating activation.' 2 Moreover, the susceptibility to this autoimmune disease is regulated by major histocompatibility complex genes. Thus the risk of developing RA is associated with DR4
antigens. 3 4 In the past, numerous models of experimentally Accepted for publication 17 March 1987. Correspondence to Dr Catherine Fournier, INSERM U283. H6pital Cochin, 27 rue du Fg St-Jacques, 75674 Paris Cedex 14.
France. induced arthritis were developed using adjuvants, antigens, or type II collagen (CII) as immunising agents, with a view to analysing the pathogenesis of RA. Since patients suffering from chronic inflammatory arthritis have humoral'13 and cellular"t [12] [13] [14] [15] [16] sensitivities to collagen, collagen induced arthritis (CIA) may have relevance to the human disease.
First described in rats'7 8 and then in mice,9 the collagen induced experimental model shares a number of clinical and histological features with RA. 2' Likewise, susceptibility to CIA is under genetic control in both ratS22 23 and mice.20' 24 Moreover, the formation of a synovial pannus and the accompanying articular cartilage erosion are two morphological manifestations of CIA. This experimental disease, however, is provoked by injection of a xenogeneic protein probably carrying species specific determinants that may be immunogenic and contribute to the development of the arthritis. 691 Therefore, we attempted to induce an experimental autoimmune arthritis (EAA) that would more closely mimic the human RA by injecting native CII of murine origin into the susceptible DBA/1 mice. with a non-arthritic limb from a control mouse.
As shown in Table 2 the onset of arthritis was significantly delayed when the mice received homologous CII in comparison with immunisation with heterologous CII. Evaluation of the arthritic score showed that the disease severity was not significantly different in the group of male mice injected with mouse CII than in those injected with bovine CII (Table 2 ). In the latter case the disease developed explosively one month after the administration of the xenogeneic protein and the maximum severity was rapidly attained. After the acute phase, exacerbation of the arthritis did not occur spontaneously. In contrast, the disease provoked by the mouse CII injection was much more progressive and its evolution fluctuated between remissions and exacerbations even after a single injection of CII. Fig. 2 Weeks showed very high autoantibody levels which peaked 13 weeks after priming (Fig. 6 ). body production in mice All the serum samples from the mice in group I amples were individually were tested for their cross reactivities with mouse ainst mouse CII and means the males (@-@) or the and bovine CII Several observations can be in-!d with mouse CII and for ferred from the results shown in Fig. 7 remission, the first macroscopic signs of EAA occurred later and progressively. After an acute inflammatory episode the affected joints gradually and partially recovered, and several days or weeks later the disease recurred affecting the same or other joints. In a recent study Holmdahl et al reached identical conclusions, although their overall incidence of arthritis (30%) after administration of homologous CII to male and female mice was lower than in our experiments (58-5% in the two groups combined).26 Since the regimen for the induction of arthritis differed in the two studies it is possible that the immunisation protocol represents a critical point for the development of the disease. With respect to the histological features of EAA, cellular hyperplasia of the synovial membrane was always observed in the affected joints, even though the pathological changes were moderate, and the inflammatory cell infiltrate was less intense in the polyarthritis induced with the homologous than with the heterologous CII. It is possible that more severe histological lesions may be observed at the initiation or during the course of the disease, which then regressed since, at the time of deaths animals showed only mild synovitis. This possibility is under investigation in our laboratory. Interestingly, in our model the clinical patterns and the kinetics were highly variable from one mouse to another. Such clinical evolution resembles that of human RA, and therefore our experimental model would be a useful tool for the study of the self-perpetuating mechanisms that characterise RA.
In contrast with the human disease, however, the females were significantly less susceptible to the induction of arthritis than were the males. In addition, the few females that developed arthritis after immunisation with homologous CII showed mild disease states. These findings are reminiscent of ankylosing spondylitis. The sex linkage of EAA that we observed is consistent with a recent report 7 but is not supported by findings described earlier in female rats17 18 or in mice.211 It is unlikely that the weak susceptibility of females to EAA induction is related to the amount of autoantigen injected, given that a booster injection of mouse CII in IFA failed to augment the incidence of EAA, while it increased the levels of autoarntibodies produced. Rather, it seems that femrale sex hormones exert a suppressive effect on the induction of autoimmulne arthritis.-' A critical role for antibodies against native CII in the initiation of CIA has been suggested by several investigators who demonstrated that the severity of the experimental disease wCas associated with a hiiuh humoral response to the immnunisillg aMtigell.
In addition, anti-CII IgG either purified from arthritic animnal serumii samples-""' or monoclonal antibodies'4 were shown to be acti've in trainsferring the disease. In the present study we found highly variable amounts of antibodies directed against homologous CII, which did not correlate with the arthritic status of the mice. Indeed, the kinetic studies performed on our two groups of mice showed that the males secreted low aimounts of specific antibodies, which increased to reach a peak five to seven weeks after immunisation and then progressively declined. In contrast. both arthritic and non-arthritic females produced higher-levels of anti-CII IgG than did the males. OCur 
